Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
Type:
Application
Filed:
June 19, 2020
Publication date:
October 8, 2020
Applicant:
VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD
Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
Type:
Application
Filed:
June 19, 2020
Publication date:
October 8, 2020
Applicant:
VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD
Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
Type:
Grant
Filed:
December 23, 2016
Date of Patent:
September 22, 2020
Assignee:
Vifor Fresenius Medical Care Renal Pharma Ltd.
Abstract: The present invention relates to pharmaceutical composition, comprising certain phosphate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide having a certain particle size distribution for the manufacture of a pharmaceutical composition.
Type:
Application
Filed:
March 16, 2020
Publication date:
July 16, 2020
Applicant:
VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD.
Abstract: The present invention relates to pharmaceutical composition, comprising certain phosphate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide having a certain particle size distribution for the manufacture of a pharmaceutical composition.
Type:
Application
Filed:
March 16, 2020
Publication date:
July 16, 2020
Applicant:
VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD.
Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
Type:
Grant
Filed:
November 27, 2018
Date of Patent:
June 30, 2020
Assignee:
Vifor Fresenius Medical Care Renal Pharma Ltd
Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
Type:
Grant
Filed:
October 25, 2018
Date of Patent:
June 16, 2020
Assignee:
Vifor Fresenius Medical Care Renal Pharma Ltd
Abstract: The present invention relates to pharmaceutical composition, comprising certain phosphate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide having a certain particle size distribution for the manufacture of a pharmaceutical composition.
Type:
Grant
Filed:
November 26, 2014
Date of Patent:
April 21, 2020
Assignee:
Vifor Fresenius Medical Care Renal Pharma Ltd.
Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
Type:
Grant
Filed:
November 13, 2008
Date of Patent:
February 7, 2017
Assignee:
Vifor Fresenius Medical Care Renal Pharma Ltd.